[
  {
    "question": {
      "question_id": "cs03_q04_action",
      "scope_id": "clinical_signal_03",
      "checkpoint_after": 30,
      "question_type": "action_recommendation",
      "prompt": "What protocol amendments should the DSMB recommend?",
      "ground_truth": {
        "canonical_answer": "Exclude concomitant statin use from the trial. Add CYP3A4 interaction screening. Implement more frequent hepatic panel monitoring for enrolled subjects. Consider dose adjustment studies for the LNS-4821/statin interaction.",
        "required_evidence_refs": [
          "clinical_signal_03_ep_019",
          "clinical_signal_03_ep_023",
          "clinical_signal_03_ep_026"
        ],
        "key_facts": [
          "the hepatic enzyme pattern is consistent with a drug-drug interaction mediated through shared hepatic metabolism pathways, not direct hepatotoxicity",
          "ALT elevations are concentrated in subjects receiving concurrent statin therapy, with higher-dose statin subgroups showing proportionally greater enzyme increases",
          "musculoskeletal safety endpoints track within expected ranges, confirming the safety signal is organ-specific to the liver"
        ]
      }
    },
    "answer": {
      "question_id": "cs03_q04_action",
      "answer_text": "Based on the available information, there is no explicit mention of specific protocol amendments that the DSMB should recommend. The retrieved documents primarily contain enrollment summaries and site-level data across different dates but do not include DSMB recommendations or proposed changes to the study protocol [ref_id: clinical_signal_03_ep_024, clinical_signal_03_ep_009, clinical_signal_03_ep_026, clinical_signal_03_ep_028, clinical_signal_03_ep_027, clinical_signal_03_ep_023, clinical_signal_03_ep_004]. Therefore, insufficient evidence exists to determine what protocol amendments the DSMB should recommend.",
      "turns": [
        {
          "role": "assistant",
          "content": "",
          "tool_calls": [
            {
              "id": "call_35ae18fc2af1440db0b8b4f5",
              "name": "memory_capabilities",
              "arguments": {}
            }
          ],
          "tokens_used": 742
        },
        {
          "role": "tool",
          "tool_results": [
            {
              "tool_call_id": "call_35ae18fc2af1440db0b8b4f5",
              "content": "{\"search_modes\": [\"keyword\", \"semantic\"], \"filter_fields\": [{\"name\": \"scope_id\", \"field_type\": \"string\", \"description\": \"Filter by scope ID\", \"enum_values\": null}, {\"name\": \"start_date\", \"field_type\": \"string\", \"description\": \"Filter episodes after this ISO date\", \"enum_values\": null}, {\"name\": \"end_date\", \"field_type\": \"string\", \"description\": \"Filter episodes before this ISO date\", \"enum_values\": null}], \"max_results_per_search\": 7, \"supports_date_range\": true, \"extra_tools\": [{\"name\": \"batch_retrieve\", \"description\": \"Retrieve multiple full documents by their reference IDs in a single call. PREFER this over calling memory_retrieve multiple times \\u2014 it is far more efficient and uses only one tool call instead of one per document. After memory_search, pass all ref_ids you want to read to this tool.\", \"parameters\": {\"type\": \"object\", \"properties\": {\"ref_ids\": {\"type\": \"array\", \"items\": {\"type\": \"string\"}, \"description\": \"List of reference IDs to retrieve (from search results).\"}}, \"required\": [\"ref_ids\"]}}]}",
              "is_error": false
            }
          ],
          "tokens_used": 0
        },
        {
          "role": "assistant",
          "content": "",
          "tool_calls": [
            {
              "id": "call_51467255dba14a99a21516b5",
              "name": "memory_search",
              "arguments": {
                "query": "DSMB protocol amendments recommendation",
                "filters": {}
              }
            }
          ],
          "tokens_used": 1040
        },
        {
          "role": "tool",
          "tool_results": [
            {
              "tool_call_id": "call_51467255dba14a99a21516b5",
              "content": "[{\"ref_id\": \"clinical_signal_03_ep_024\", \"text\": \"## 2024-08-12 Daily Operations Summary\\n\\n### Enrollment\\n- Total Randomized: 244\\n- Active: 236\\n- Screen Failures Cumulative: 49\\n- Withdrawals Cumulative: 8\\n\\n### Sites\\n- Site 01\\n  - Enrolled: 25\\n  - Active: 25\\n  - Statin Concomitant: 6\\n- Site 02\\n  - Enrolled: 18\\n  - Active: 18\\n  - Statin Concomitant: 5\\n- Site 03\\n  - Enrolled: 22\\n  - Active: 22\\n  - Statin Concomitant: 7\\n- Site 04\\n  - Enrolled: 16\\n  - Active: 16\\n  - Statin Concomitant: 5\\n- Site 05\\n  - Enrolled: 20\\n  - Active: 20\\n  - Statin Concomitan\", \"score\": 0.03177805800756621, \"metadata\": {\"episode_type\": \"signal\", \"phase\": \"root_cause\", \"signal_density\": \"high\"}}, {\"ref_id\": \"clinical_signal_03_ep_009\", \"text\": \"## 2024-04-29 Daily Operations Summary\\n\\n### Enrollment\\n- Total Randomized: 185\\n- Active: 180\\n- Screen Failures Cumulative: 22\\n- Withdrawals Cumulative: 5\\n\\n#### Sites\\n- Site 01 Enrolled: 18\\n- Site 01 Active: 18\\n- Site 01 Statin Concomitant: 5\\n- Site 02 Enrolled: 14\\n- Site 02 Active: 14\\n- Site 02 Statin Concomitant: 4\\n- Site 03 Enrolled: 17\\n- Site 03 Active: 17\\n- Site 03 Statin Concomitant: 4\\n- Site 04 Enrolled: 12\\n- Site 04 Active: 12\\n- Site 04 Statin Concomitant: 3\\n- Site 05 Enrolled: 15\\n- Site \", \"score\": 0.030776515151515152, \"metadata\": {\"episode_type\": \"signal\", \"phase\": \"early_signal\", \"signal_density\": \"low\"}}, {\"ref_id\": \"clinical_signal_03_ep_026\", \"text\": \"## 2024-08-26 Daily Operations Summary\\n\\n### Enrollment\\n- Total Randomized: 234\\n- Active: 220\\n- Screen Failures Cumulative: 69\\n- Withdrawals Cumulative: 14\\n\\n#### Sites\\n- Site 01 Enrolled: 24\\n- Site 01 Active: 23\\n- Site 01 Statin Concomitant: 6\\n- Site 02 Enrolled: 17\\n- Site 02 Active: 16\\n- Site 02 Statin Concomitant: 5\\n- Site 03 Enrolled: 22\\n- Site 03 Active: 21\\n- Site 03 Statin Concomitant: 7\\n- Site 04 Enrolled: 16\\n- Site 04 Active: 15\\n- Site 04 Statin Concomitant: 5\\n- Site 05 Enrolled: 19\\n- Site\", \"score\": 0.030776515151515152, \"metadata\": {\"episode_type\": \"signal\", \"phase\": \"root_cause\", \"signal_density\": \"high\"}}, {\"ref_id\": \"clinical_signal_03_ep_028\", \"text\": \"## 2024-09-09 Daily Operations Summary\\n\\n### Enrollment\\n- Total Randomized: 220\\n- Active: 200\\n- Screen Failures Cumulative: 48\\n- Withdrawals Cumulative: 20\\n\\n#### Sites\\n- Site 01 Enrolled: 22\\n- Site 01 Active: 21\\n- Site 01 Statin Concomitant: 6\\n- Site 02 Enrolled: 16\\n- Site 02 Active: 16\\n- Site 02 Statin Concomitant: 4\\n- Site 03 Enrolled: 20\\n- Site 03 Active: 19\\n- Site 03 Statin Concomitant: 5\\n- Site 04 Enrolled: 15\\n- Site 04 Active: 15\\n- Site 04 Statin Concomitant: 4\\n- Site 05 Enrolled: 18\\n- Site\", \"score\": 0.030309988518943745, \"metadata\": {\"episode_type\": \"signal\", \"phase\": \"root_cause\", \"signal_density\": \"high\"}}, {\"ref_id\": \"clinical_signal_03_ep_027\", \"text\": \"## 2024-09-02 Daily Operations Summary\\n\\n### Enrollment\\n- Total Randomized: 218\\n- Active: 202\\n- Screen Failures Cumulative: 68\\n- Withdrawals Cumulative: 16\\n\\n#### Sites\\n- Site 01 Enrolled: 22\\n- Site 01 Active: 21\\n- Site 01 Statin Concomitant: 6\\n- Site 02 Enrolled: 16\\n- Site 02 Active: 15\\n- Site 02 Statin Concomitant: 4\\n- Site 03 Enrolled: 20\\n- Site 03 Active: 19\\n- Site 03 Statin Concomitant: 5\\n- Site 04 Enrolled: 14\\n- Site 04 Active: 14\\n- Site 04 Statin Concomitant: 3\\n- Site 05 Enrolled: 18\\n- Site\", \"score\": 0.030158730158730156, \"metadata\": {\"episode_type\": \"signal\", \"phase\": \"root_cause\", \"signal_density\": \"high\"}}, {\"ref_id\": \"clinical_signal_03_ep_023\", \"text\": \"## 2024-08-05 Daily Operations Summary\\n\\n### Enrollment\\n- Total Randomized: 210\\n- Active: 196\\n- Screen Failures Cumulative: 58\\n- Withdrawals Cumulative: 14\\n\\n### Sites\\n- Site 01 Enrolled: 21\\n- Site 01 Active: 21\\n- Site 01 Statin Concomitant: 7\\n- Site 02 Enrolled: 16\\n- Site 02 Active: 16\\n- Site 02 Statin Concomitant: 4\\n- Site 03 Enrolled: 19\\n- Site 03 Active: 19\\n- Site 03 Statin Concomitant: 6\\n- Site 04 Enrolled: 14\\n- Site 04 Active: 14\\n- Site 04 Statin Concomitant: 3\\n- Site 05 Enrolled: 17\\n- Site \", \"score\": 0.02964254577157803, \"metadata\": {\"episode_type\": \"signal\", \"phase\": \"root_cause\", \"signal_density\": \"high\"}}, {\"ref_id\": \"clinical_signal_03_ep_004\", \"text\": \"## 2024-03-25 Daily Operations Summary\\n\\n### Enrollment\\n- Total Randomized: 100\\n- Active: 98\\n- Screen Failures Cumulative: 11\\n- Withdrawals Cumulative: 2\\n\\n#### Sites\\n- Site 01\\n  - Enrolled: 10\\n  - Active: 10\\n  - Statin Concomitant: 2\\n- Site 02\\n  - Enrolled: 7\\n  - Active: 7\\n  - Statin Concomitant: 1\\n- Site 03\\n  - Enrolled: 9\\n  - Active: 9\\n  - Statin Concomitant: 2\\n- Site 04\\n  - Enrolled: 6\\n  - Active: 6\\n  - Statin Concomitant: 1\\n- Site 05\\n  - Enrolled: 8\\n  - Active: 8\\n  - Statin Concomitant: 2\\n- S\", \"score\": 0.029386529386529386, \"metadata\": {\"episode_type\": \"signal\", \"phase\": \"baseline\", \"signal_density\": \"none\"}}]",
              "is_error": false
            }
          ],
          "tokens_used": 0
        },
        {
          "role": "assistant",
          "content": "",
          "tool_calls": [
            {
              "id": "call_76d8b43ca21c423a8fedf370",
              "name": "memory_search",
              "arguments": {
                "query": "DSMB recommendations protocol amendments",
                "filters": {}
              }
            }
          ],
          "tokens_used": 3159
        },
        {
          "role": "tool",
          "tool_results": [
            {
              "tool_call_id": "call_76d8b43ca21c423a8fedf370",
              "content": "[Context budget exhausted \u2014 synthesize answer from evidence already retrieved]",
              "is_error": false
            }
          ],
          "tokens_used": 0
        },
        {
          "role": "assistant",
          "content": "Based on the available information, there is no explicit mention of specific protocol amendments that the DSMB should recommend. The retrieved documents primarily contain enrollment summaries and site-level data across different dates but do not include DSMB recommendations or proposed changes to the study protocol [ref_id: clinical_signal_03_ep_024, clinical_signal_03_ep_009, clinical_signal_03_ep_026, clinical_signal_03_ep_028, clinical_signal_03_ep_027, clinical_signal_03_ep_023, clinical_signal_03_ep_004]. Therefore, insufficient evidence exists to determine what protocol amendments the DSMB should recommend.",
          "tokens_used": 3332
        }
      ],
      "tool_calls_made": 3,
      "total_tokens": 8273,
      "wall_time_ms": 11606.490617035888,
      "budget_violations": [
        "Cumulative result token limit exceeded: 2692 > 2048"
      ],
      "refs_cited": []
    },
    "retrieved_ref_ids": [],
    "valid_ref_ids": []
  }
]